Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Daniel Merrick

Concepts (332)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
43
2026
2652
2.900
Why?
Precancerous Conditions
13
2026
166
2.530
Why?
Carcinoma, Squamous Cell
15
2024
643
1.870
Why?
Carcinoma, Non-Small-Cell Lung
14
2026
1183
1.340
Why?
Adenocarcinoma
7
2019
931
0.580
Why?
B7-H1 Antigen
3
2026
241
0.450
Why?
Biopsy
9
2026
1079
0.440
Why?
Bronchi
6
2018
267
0.430
Why?
Chemoprevention
4
2019
90
0.420
Why?
Biomarkers, Tumor
9
2026
1325
0.390
Why?
ErbB Receptors
6
2023
630
0.380
Why?
Disease Progression
7
2019
2855
0.360
Why?
Carmustine
3
2020
52
0.360
Why?
Neovascularization, Pathologic
5
2015
286
0.350
Why?
Heat-Shock Proteins
1
2012
138
0.340
Why?
Bronchial Neoplasms
2
2011
15
0.330
Why?
Papillomaviridae
4
1996
115
0.320
Why?
Polymorphism, Genetic
1
2012
612
0.300
Why?
Proto-Oncogene Proteins
3
2018
624
0.290
Why?
Smoke
3
2020
148
0.290
Why?
Gene Expression Regulation, Neoplastic
7
2026
1462
0.290
Why?
Keratinocytes
4
1996
250
0.290
Why?
Lung Diseases
1
2015
790
0.280
Why?
Cell Transformation, Neoplastic
4
2024
339
0.280
Why?
Smoking
6
2019
1472
0.280
Why?
Protein Kinase Inhibitors
4
2026
974
0.280
Why?
Lung
10
2025
4112
0.270
Why?
Gene Dosage
3
2016
148
0.270
Why?
Formaldehyde
2
2025
66
0.260
Why?
Carcinogenesis
2
2020
229
0.250
Why?
Inflammation
1
2018
2881
0.250
Why?
Epoprostenol
2
2018
131
0.250
Why?
Iloprost
4
2018
44
0.240
Why?
Carcinogens
5
2018
123
0.240
Why?
Mice
23
2026
18397
0.230
Why?
Humans
56
2026
145307
0.230
Why?
In Situ Hybridization, Fluorescence
3
2018
323
0.210
Why?
Sputum
4
2019
308
0.210
Why?
Mutation
6
2023
4104
0.210
Why?
Immunohistochemistry
5
2015
1718
0.200
Why?
Mast Cells
1
2025
146
0.200
Why?
Cardiomyopathy, Hypertrophic, Familial
1
2003
15
0.200
Why?
Neoplasm Invasiveness
4
2015
510
0.190
Why?
Chest Pain
1
2003
100
0.190
Why?
Desmoglein 3
2
2022
14
0.190
Why?
Cell Proliferation
4
2018
2506
0.180
Why?
Lidocaine
1
2022
54
0.180
Why?
Vascular Endothelial Growth Factor A
1
2005
557
0.180
Why?
Epithelial-Mesenchymal Transition
3
2022
220
0.180
Why?
Gelatin
1
2022
56
0.180
Why?
Inflammation Mediators
1
2025
509
0.180
Why?
Neoplasms
3
2026
2887
0.180
Why?
Neuropilin-1
1
2021
8
0.180
Why?
Gene Expression Profiling
3
2026
1787
0.180
Why?
Animals
24
2026
38180
0.180
Why?
Male
31
2026
72629
0.170
Why?
Image Processing, Computer-Assisted
1
2026
782
0.170
Why?
Ki-67 Antigen
2
2015
117
0.170
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
86
0.170
Why?
Middle Aged
20
2026
36021
0.170
Why?
Female
31
2026
78605
0.170
Why?
Cysts
1
2021
111
0.160
Why?
Receptor, IGF Type 1
2
2010
64
0.160
Why?
Aged
14
2026
26001
0.160
Why?
Granulomatosis with Polyangiitis
1
2020
47
0.150
Why?
Biomedical Research
1
2026
713
0.150
Why?
Respiratory System
1
2020
149
0.150
Why?
Carcinoma in Situ
1
2019
44
0.150
Why?
Cell Cycle Proteins
2
2018
630
0.150
Why?
Disease Models, Animal
5
2020
4580
0.150
Why?
Air Pollution
1
2023
327
0.150
Why?
Pneumonia
1
2025
631
0.150
Why?
gamma Catenin
1
2018
13
0.140
Why?
Fluorescent Antibody Technique
1
2019
370
0.140
Why?
Exons
1
2020
361
0.140
Why?
Metaplasia
1
2018
57
0.140
Why?
Drug Resistance, Neoplasm
3
2023
886
0.140
Why?
Bronchial Diseases
1
2018
38
0.140
Why?
Mucin 5AC
1
2018
70
0.140
Why?
Air Pollutants
1
2023
439
0.140
Why?
Tobacco Smoke Pollution
1
2020
233
0.140
Why?
MicroRNAs
2
2016
701
0.140
Why?
Anticarcinogenic Agents
1
2018
61
0.130
Why?
Cell Cycle Checkpoints
1
2018
99
0.130
Why?
Urethane
4
2023
43
0.120
Why?
Aged, 80 and over
7
2017
8295
0.120
Why?
Cell Transformation, Viral
2
1993
23
0.120
Why?
RNA, Messenger
5
2022
2833
0.120
Why?
Head and Neck Neoplasms
1
2021
562
0.120
Why?
Frizzled Receptors
1
2016
25
0.120
Why?
Antigen Presentation
1
2017
205
0.120
Why?
Prognosis
6
2026
4310
0.120
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
154
0.120
Why?
Oncogene Proteins, Fusion
1
2018
211
0.120
Why?
Porphyrins
1
2015
16
0.120
Why?
Proto-Oncogene Proteins c-met
1
2016
76
0.110
Why?
Tomography, Spiral Computed
1
2015
30
0.110
Why?
Oncogenes
1
2016
119
0.110
Why?
Adult
13
2026
40627
0.110
Why?
Myocardial Infarction
1
2003
1211
0.110
Why?
Topoisomerase Inhibitors
1
2015
4
0.110
Why?
Smad4 Protein
1
2015
34
0.110
Why?
Protein-Tyrosine Kinases
1
2018
433
0.110
Why?
Bronchopulmonary Dysplasia
1
2019
410
0.100
Why?
Chromosomal Instability
1
2013
21
0.100
Why?
Macrophages, Alveolar
2
2023
368
0.100
Why?
Mice, Transgenic
5
2018
2192
0.100
Why?
Microarray Analysis
1
2013
117
0.100
Why?
Stem Cells
1
2018
627
0.100
Why?
Neoplasms, Basal Cell
1
2013
4
0.100
Why?
Obesity
1
2007
3085
0.100
Why?
Trachea
1
2015
261
0.100
Why?
Endoscopy
1
2015
316
0.090
Why?
Interleukin-1
1
1996
961
0.090
Why?
Tretinoin
1
1993
124
0.090
Why?
Quinazolines
2
2012
266
0.090
Why?
Piperidines
2
2012
218
0.090
Why?
Receptors, Transforming Growth Factor beta
1
2012
57
0.090
Why?
B-Lymphocytes
1
2017
877
0.090
Why?
Antigens, Differentiation
1
1992
77
0.090
Why?
PTEN Phosphohydrolase
1
2013
165
0.090
Why?
Cohort Studies
3
2023
5982
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2012
983
0.080
Why?
CD4-Positive T-Lymphocytes
1
2017
1130
0.080
Why?
Cell Line
4
2019
2882
0.080
Why?
Hyperplasia
1
2011
177
0.080
Why?
Tissue Array Analysis
3
2019
50
0.080
Why?
Receptor Protein-Tyrosine Kinases
1
2012
230
0.080
Why?
Diagnosis, Differential
3
2021
1500
0.080
Why?
Epithelium
4
2018
314
0.080
Why?
Pulmonary Disease, Chronic Obstructive
1
2018
923
0.080
Why?
Pulmonary Surgical Procedures
1
2010
8
0.080
Why?
Early Detection of Cancer
1
2015
469
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1962
0.080
Why?
Pulmonary Alveoli
1
2012
383
0.080
Why?
Nuclear Proteins
3
2006
750
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2005
851
0.070
Why?
Vasodilator Agents
1
2011
331
0.070
Why?
Cell Polarity
1
2010
137
0.070
Why?
Small Cell Lung Carcinoma
1
2010
119
0.070
Why?
Epithelial Cells
4
2018
1126
0.070
Why?
Neoplasm Staging
3
2020
1470
0.070
Why?
Follow-Up Studies
2
2015
5431
0.070
Why?
Receptors, Fibroblast Growth Factor
1
2008
70
0.070
Why?
Solitary Fibrous Tumor, Pleural
1
2008
3
0.070
Why?
Osteoarthropathy, Secondary Hypertrophic
1
2008
3
0.070
Why?
Smokers
2
2019
137
0.070
Why?
Echocardiography
2
2003
656
0.070
Why?
Neoplasms, Experimental
2
2018
173
0.070
Why?
Prevalence
3
2023
2838
0.070
Why?
Edema
1
2008
124
0.060
Why?
Fibroblast Growth Factors
1
2008
188
0.060
Why?
Carcinoma, Small Cell
1
2008
173
0.060
Why?
Monocytes
1
2010
538
0.060
Why?
Gene Expression Regulation
1
2016
2609
0.060
Why?
Radiography, Thoracic
1
2008
171
0.060
Why?
Genome-Wide Association Study
1
2013
1414
0.060
Why?
Bronchoalveolar Lavage Fluid
2
2025
636
0.060
Why?
Minichromosome Maintenance Complex Component 2
1
2006
4
0.060
Why?
Placebos
2
2019
193
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2152
0.060
Why?
Hydrogels
2
2023
701
0.060
Why?
United Kingdom
1
2007
338
0.060
Why?
Mice, Inbred C57BL
3
2025
6009
0.060
Why?
Survival Rate
2
2026
2100
0.060
Why?
Biomarkers
4
2023
4284
0.060
Why?
Mice, Inbred A
2
2020
48
0.060
Why?
Cell Movement
2
2025
965
0.060
Why?
Transcription Factors
1
1993
1746
0.060
Why?
Treatment Outcome
5
2022
11731
0.060
Why?
Tumor Microenvironment
2
2021
736
0.060
Why?
Gene Rearrangement
1
2026
155
0.060
Why?
Environment
1
2007
306
0.060
Why?
Chromosome Aberrations
2
2017
163
0.050
Why?
Proto-Oncogene Proteins p21(ras)
2
2018
253
0.050
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
109
0.050
Why?
Bronchoscopy
2
2019
227
0.050
Why?
Specimen Handling
1
2026
186
0.050
Why?
Hypoxia
1
2012
1200
0.050
Why?
Global Health
1
2007
403
0.050
Why?
Prospective Studies
4
2023
8011
0.050
Why?
Japan
1
2003
145
0.050
Why?
Gene Knockdown Techniques
2
2015
336
0.050
Why?
Acrylamides
1
2023
72
0.050
Why?
Keratin-5
1
2022
48
0.050
Why?
Socioeconomic Factors
1
2007
1327
0.050
Why?
Aniline Compounds
1
2023
119
0.040
Why?
Alveolar Epithelial Cells
1
2023
120
0.040
Why?
Diagnostic Errors
1
2003
177
0.040
Why?
Up-Regulation
1
2005
853
0.040
Why?
Signal Transduction
3
2012
5239
0.040
Why?
Immunoenzyme Techniques
2
2012
200
0.040
Why?
Molecular Targeted Therapy
2
2018
434
0.040
Why?
Adaptive Immunity
1
2023
169
0.040
Why?
Mice, Inbred BALB C
2
2011
1253
0.040
Why?
Particle Size
1
2023
412
0.040
Why?
Dendritic Cells
1
2025
499
0.040
Why?
Interferon-gamma
2
2018
784
0.040
Why?
PPAR gamma
1
2022
177
0.040
Why?
Tubulin
1
2022
147
0.040
Why?
Sensitivity and Specificity
1
2006
1992
0.040
Why?
Interleukin-1beta
1
2023
395
0.040
Why?
Double-Blind Method
2
2019
2033
0.040
Why?
Incidence
2
2008
2892
0.040
Why?
Acute Disease
1
2003
1031
0.040
Why?
Exercise Test
1
2003
635
0.040
Why?
Oximes
1
2020
26
0.040
Why?
Particulate Matter
1
2023
347
0.040
Why?
Electrocardiography
1
2003
663
0.040
Why?
Blotting, Western
2
2012
1187
0.040
Why?
Pyrimidinones
1
2020
126
0.040
Why?
Pyrimidines
1
2023
533
0.040
Why?
Amino Acid Substitution
1
2020
304
0.040
Why?
Rituximab
1
2020
211
0.040
Why?
Cell Line, Transformed
2
1996
140
0.040
Why?
T-Lymphocytes, Regulatory
1
2021
389
0.040
Why?
Indoles
1
2023
501
0.040
Why?
Imidazoles
1
2020
254
0.040
Why?
Remission Induction
1
2019
308
0.030
Why?
Tobacco Smoking
1
2018
26
0.030
Why?
Diagnostic Imaging
1
2021
342
0.030
Why?
Intramolecular Oxidoreductases
1
2018
66
0.030
Why?
Environmental Exposure
1
2023
594
0.030
Why?
RNA
1
2005
940
0.030
Why?
Pyridones
1
2020
200
0.030
Why?
Breast Neoplasms
1
2011
2464
0.030
Why?
Tricuspid Valve
1
1998
41
0.030
Why?
Time
1
2018
86
0.030
Why?
RNA, Small Interfering
2
2012
635
0.030
Why?
Proto-Oncogene Proteins B-raf
1
2020
226
0.030
Why?
Ventricular Outflow Obstruction
1
1998
40
0.030
Why?
Cytochrome P-450 Enzyme System
1
2018
162
0.030
Why?
Risk Factors
3
2019
10816
0.030
Why?
Lymphocyte Count
1
2017
164
0.030
Why?
Tumor Burden
1
2018
323
0.030
Why?
DNA Copy Number Variations
1
2018
183
0.030
Why?
Antigen-Presenting Cells
1
2017
160
0.030
Why?
Carcinogenicity Tests
1
1996
10
0.030
Why?
Mass Screening
2
2004
1357
0.030
Why?
Diabetes Mellitus
1
2006
1098
0.030
Why?
Structure-Activity Relationship
1
2018
570
0.030
Why?
Immunotherapy
1
2021
660
0.030
Why?
Blotting, Northern
1
1996
204
0.030
Why?
Neoplasms, Glandular and Epithelial
1
1996
49
0.030
Why?
Cells, Cultured
2
2016
4156
0.030
Why?
Neoplasm Transplantation
1
1996
252
0.030
Why?
Immunophenotyping
1
2017
322
0.030
Why?
Centrosome
1
2016
71
0.030
Why?
Plasmids
1
1996
379
0.030
Why?
Mitotic Index
1
2015
25
0.030
Why?
Smoking Cessation
1
2019
439
0.030
Why?
Survival Analysis
1
2018
1386
0.030
Why?
Mice, Nude
1
1996
688
0.030
Why?
Cell Differentiation
2
1993
2053
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2018
550
0.030
Why?
Phenotype
2
1993
3173
0.030
Why?
Neoplasm Grading
1
2015
310
0.030
Why?
Loss of Heterozygosity
1
2013
52
0.030
Why?
Retinoid X Receptors
1
1993
38
0.030
Why?
Receptors, Retinoic Acid
1
1993
42
0.020
Why?
Lymphocyte Activation
1
2017
1127
0.020
Why?
Organ Culture Techniques
1
1993
154
0.020
Why?
Uterine Cervical Neoplasms
1
1996
270
0.020
Why?
Computational Biology
1
2018
683
0.020
Why?
Drug Resistance
1
1993
153
0.020
Why?
Cytosol
1
1993
227
0.020
Why?
Models, Molecular
1
2018
1619
0.020
Why?
Macrophages
1
2020
1514
0.020
Why?
DNA Repair
1
2015
256
0.020
Why?
Methylcholanthrene
1
2012
21
0.020
Why?
c-Mer Tyrosine Kinase
1
2012
38
0.020
Why?
Butylated Hydroxytoluene
1
2012
36
0.020
Why?
Cell Line, Tumor
2
2012
3560
0.020
Why?
Respiratory Mucosa
1
2015
322
0.020
Why?
Immunoprecipitation
1
2012
151
0.020
Why?
Proliferating Cell Nuclear Antigen
1
1992
49
0.020
Why?
Intermediate Filament Proteins
1
1992
57
0.020
Why?
Receptors, Cytoplasmic and Nuclear
1
1993
210
0.020
Why?
Gene Deletion
1
2013
389
0.020
Why?
Administration, Topical
1
2011
150
0.020
Why?
Keratins
1
1992
172
0.020
Why?
Mutation, Missense
1
2013
340
0.020
Why?
Sleep Apnea Syndromes
1
2012
97
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2012
167
0.020
Why?
United States
2
2011
16051
0.020
Why?
Carcinoma, Large Cell
1
2010
17
0.020
Why?
Administration, Oral
1
2012
848
0.020
Why?
Antineoplastic Agents
2
2012
2202
0.020
Why?
RNA Interference
1
2012
476
0.020
Why?
Cell Division
1
1992
766
0.020
Why?
Severity of Illness Index
1
2018
2926
0.020
Why?
Mice, Inbred Strains
1
2010
397
0.020
Why?
Aneuploidy
1
2010
91
0.020
Why?
Interleukin-4
1
2010
206
0.020
Why?
Xenograft Model Antitumor Assays
1
2012
931
0.020
Why?
Antioxidants
1
2012
549
0.020
Why?
Disease-Free Survival
1
2010
771
0.020
Why?
Kaplan-Meier Estimate
1
2010
967
0.020
Why?
Proportional Hazards Models
1
2010
1328
0.020
Why?
Cross-Sectional Studies
1
2018
5883
0.010
Why?
Asia
1
2006
71
0.010
Why?
Dose-Response Relationship, Drug
1
2010
2032
0.010
Why?
Skin
1
1991
758
0.010
Why?
Databases, Nucleic Acid
1
2005
39
0.010
Why?
England
1
2006
111
0.010
Why?
Enzymes
1
2005
65
0.010
Why?
Age Distribution
1
2006
403
0.010
Why?
Case-Control Studies
1
2012
3613
0.010
Why?
Sex Distribution
1
2006
386
0.010
Why?
Species Specificity
1
2005
574
0.010
Why?
Cytokines
1
2012
2066
0.010
Why?
Cluster Analysis
1
2005
521
0.010
Why?
Apoptosis
1
2012
2430
0.010
Why?
DNA Replication
1
2005
252
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2005
758
0.010
Why?
Age Factors
1
2011
3339
0.010
Why?
Antibodies, Monoclonal
1
2010
1525
0.010
Why?
Body Weight
1
2006
980
0.010
Why?
Models, Statistical
1
2006
682
0.010
Why?
Young Adult
1
2018
14163
0.010
Why?
Risk Assessment
1
2010
3686
0.010
Why?
Time Factors
1
2010
7186
0.010
Why?
Retrospective Studies
1
2016
17149
0.010
Why?
Echocardiography, Transesophageal
1
1998
134
0.010
Why?
Infant
1
2006
10101
0.010
Why?
Culture Techniques
1
1991
67
0.010
Why?
Diabetes Mellitus, Type 2
1
2006
2592
0.010
Why?
Child, Preschool
1
2006
11863
0.010
Why?
Reference Values
1
1991
798
0.000
Why?
Diabetes Mellitus, Type 1
1
2006
3906
0.000
Why?
Adolescent
1
2006
22507
0.000
Why?
Child
1
2006
22712
0.000
Why?
Merrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)